Agenda
- Overview of RSV illness and vaccine development in older adults
- RSV illness burden in older adults and the need for RSV vaccine
- Risk factors for severe RSV illness in the adult population
- Comorbid conditions of concern in RSV infection
- Overview of strategies under development for RSV prevention
- Key clinical data on RSV vaccines under development in older adults
- Discussion on practical considerations in implementation of vaccine in older adults, including long-term care settings
- Question and answer session
Events
Date / Time
Event Details
Faculty
Faculty
Spencer Durham, PharmD, BCPS, BCIDP
Associate Clinical Professor of Pharmacy Practice
Mahlon G. Turner Pharmacy Fellow in Outreach
Director, Alumni & Professional Affairs
Auburn University Harrison School of Pharmacy
Auburn, Alabama
Faculty
Stefan Gravenstein, MD, MPH
Director, Division of Geriatrics and Palliative Medicine
The Warren Alpert Medical School of Brown University
Providence, Rhode Island
Faculty
Barbara Resnick, PhD, CRNP
Professor
School of Nursing
University of Maryland
Baltimore, Maryland
Goal Statement
The goal of this activity is to improve learners’ competence in identifying respiratory syncytial virus in older adults and understanding the ongoing prevention clinical research.
Target Audience
This program is intended for physicians, pharmacists, advanced practice nurses, and other healthcare providers caring for older adults at risk of severe RSV disease.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Assess risk for severe RSV development in adults according to age and comorbid conditions
- Outline vaccine strategies under evaluation for RSV in older adults
- Apply guideline and data-based RSV prevention strategies in older adults as they become available
Accreditation
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.
Continuing Pharmacy Education
CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-21-117-L01-P
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.